Stay updated on PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Page revision label updated from v3.5.4 to v3.5.5, reflecting a newer build version. This metadata-level change does not alter the study details, eligibility criteria, or results information presented on the page.
    Difference
    0.0%
    Check dated 2026-06-05T11:22:50.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.3 to v3.5.4, signaling a newer version of the page. This update reflects a backend or content refresh without altering the displayed study details.
    Difference
    0.0%
    Check dated 2026-05-14T23:06:58.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Page revision tag updated from v3.5.2 to v3.5.3, indicating a newer version of the page. This is a metadata/versioning change and does not alter the study content presented on the page.
    Difference
    0.0%
    Check dated 2026-04-30T16:16:01.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    - Revision updated from v3.5.0 to v3.5.2 on the page.
    Difference
    0.0%
    Check dated 2026-04-16T11:05:13.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Added Marinesco-Sjögren syndrome and a Genetic and Rare Diseases Information Center resources entry to the page.
    Difference
    0.1%
    Check dated 2026-04-02T04:52:49.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Revision updated to v3.5.0 and removal of v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T18:27:16.000Z thumbnail image

Stay in the know with updates to PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial page.